In Defense of Evidence-based Medicine for the Treatment of COVID-19 Acute Respiratory Distress Syndrome.

Rice, Todd W; Janz, David R

Rice, Todd W; Janz, David R.

Rice TW; Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Janz DR; University Medical Center, New Orleans, Louisiana; and.

Ann Am Thorac Soc ; 17(7): 787-789, 2020 Jul.

Article in English | MEDLINE | ID: covidwho-683366

Subject(s)

Coronavirus Infections; Critical Care; Critical Pathways; Evidence-Based Medicine; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; Betacoronavirus/isolation & purification; COVID-19; Coronavirus Infections/epidemiology; Coronavirus Infections/physiopathology; Coronavirus Infections/therapy; Critical Care/ethics; Critical Care/methods; Critical Care/standards; Critical Care Outcomes; Critical Illness/therapy; Critical Pathways/ethics; Critical Pathways/standards; Empirical Research; Evidence-Based Medicine/methods; Evidence-Based Medicine/organization & administration; Humans; Pneumonia, Viral/epidemiology; Pneumonia, Viral/physiopathology; Pneumonia, Viral/therapy; Respiration, Artificial/methods; Respiration, Artificial/standards; Respiratory Distress Syndrome/etiology; Respiratory Distress Syndrome/therapy; SARS-CoV-2; Standard of Care

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Respiratory Distress Syndrome / Coronavirus Infections / Critical Pathways / Evidence-Based Medicine / Critical Care / Pandemics Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Ann Am Thorac Soc Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google